B. Riley Weighs in on InfuSystem’s Q1 Earnings (NYSE:INFU)

InfuSystem Holdings, Inc. (NYSE:INFU) – Investment analysts at B. Riley issued their Q1 2026 EPS estimates for shares of InfuSystem in a research report issued on Thursday, May 8th. B. Riley analyst A. Schock anticipates that the company will earn $0.04 per share for the quarter. B. Riley currently has a “Strong-Buy” rating on the stock. The consensus estimate for InfuSystem’s current full-year earnings is $0.15 per share. B. Riley also issued estimates for InfuSystem’s Q2 2026 earnings at $0.06 EPS, Q3 2026 earnings at $0.09 EPS and Q4 2026 earnings at $0.11 EPS.

Several other equities analysts have also recently weighed in on the company. StockNews.com upgraded InfuSystem from a “buy” rating to a “strong-buy” rating in a research report on Friday, March 14th. Sidoti raised InfuSystem to a “strong-buy” rating in a report on Tuesday, March 18th.

InfuSystem Trading Up 4.9%

Shares of INFU stock opened at $5.75 on Monday. The stock has a market capitalization of $120.84 million, a price-to-earnings ratio of 95.85 and a beta of 1.73. The company’s fifty day simple moving average is $5.26 and its two-hundred day simple moving average is $7.14. InfuSystem has a 1 year low of $4.61 and a 1 year high of $9.97. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.98 and a quick ratio of 1.59.

Institutional Trading of InfuSystem

Institutional investors and hedge funds have recently bought and sold shares of the company. Barclays PLC increased its holdings in shares of InfuSystem by 300.5% in the third quarter. Barclays PLC now owns 28,597 shares of the company’s stock worth $192,000 after purchasing an additional 21,457 shares during the period. JPMorgan Chase & Co. increased its stake in InfuSystem by 74.1% in the 3rd quarter. JPMorgan Chase & Co. now owns 15,556 shares of the company’s stock worth $104,000 after acquiring an additional 6,623 shares during the last quarter. First Eagle Investment Management LLC raised its holdings in shares of InfuSystem by 25.9% in the 4th quarter. First Eagle Investment Management LLC now owns 908,371 shares of the company’s stock valued at $7,676,000 after acquiring an additional 186,668 shares in the last quarter. Sei Investments Co. purchased a new stake in shares of InfuSystem in the 4th quarter valued at about $90,000. Finally, Bank of New York Mellon Corp boosted its position in shares of InfuSystem by 14.3% during the 4th quarter. Bank of New York Mellon Corp now owns 91,219 shares of the company’s stock valued at $771,000 after acquiring an additional 11,436 shares during the last quarter. 71.13% of the stock is currently owned by hedge funds and other institutional investors.

About InfuSystem

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.